“We're going to Examine how the commercialization of this substance fits in with our organization product at Adastra in order to position ourselves to help the desire for a safe supply of copyright,” stated Main executive officer Michael Forbes within a news release. The corporate instructed VICE News it would not be commenting additional.Over